# Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection

> **NCT04367610** · — · COMPLETED · sponsor: **Istanbul University** · enrollment: 75 (actual)

## Conditions studied

- Antibody-mediated Rejection
- Kidney Transplant Rejection
- Graft Loss

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04367610
- **Lead sponsor:** Istanbul University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2021-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04367610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04367610, "Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04367610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
